THE EFFECT OF 5 µM DOSAGE OF AMLODIPINE ON NRF2 EXPRESSION IN NEURON CULTURE INDUCED BY 25 mM OF GLUCOSE

Authors

  • Shahdevi NK Neurology Department, Medical Faculty of Brawijaya University, Malang, Indonesia
  • Nasution MTRR Neurology Department, Medical Faculty of Brawijaya University, Malang, Indonesia
  • Machlusil H Neurology Department, Medical Faculty of Brawijaya University, Malang, Indonesia
  • Masruroh R Neurology Department, Medical Faculty of Brawijaya University, Malang, Indonesia

DOI:

https://doi.org/10.29121/granthaalayah.v8.i1.2020.283

Keywords:

Amlodipine, Diabetic Neuropathy, NRF2, SH-SY5Y

Abstract [English]

Introduction: Hyperglycemia on neuron cell culture occurs when the cells are induced by 25 mM of glucose. Hyperglycemia state will increase intracellular Ca2+ that leads to increased of oxidative stress in the cell. This causes the activation of antioxidant enzymes by Nrf2 protein. Amlodipine act on nerve cells through bounding with L-Type Calcium Channel (LTCC). 5 µM of amlodipine has neuroprotective effect on cell culture of neuron by inhibiting cell death. Aim: The purpose of this research is to know the effect of treating amlodipine dose 5 μM towards expression of the protein Nrf2 in SH-SY5Y cell culture induced by 25 mM glucose. Methods: In this research on neuron cell culture induced 25 mM glucose within 6 days and treated with amlodipine and without amlodipine 5 µM. Results: Based on research results obtained test results independent t test (p = 0,324) that there is no change of the Nrf2 expression significant between a given neuron cell culture with amlodipine without amlodipine. Spearman correlation test showed (r = 0.290; p = 0.361) that treating by amlodipine 5 µM not significantly increasing Nrf2 expression. Conclusion: Based on this study it can be concluded that treating by amlodipine 5 µM not give effect against Nrf2 expression on neuron cell culture induced 25 mM glucose.

Downloads

Download data is not yet available.

References

Akki, R., Siracusa, R., Morabito, R., Remigante, A., Campolo, M., Errami, M., La Spada, G., Cuzzocrea, S., & Marino, A. Neuronal-like differentiated SH-SY5Y cells adaptation to a mild and transient H 2 O 2 -induced oxidative stress. Cell Biochemistry and Function, March 2018, 36(2), 56–64. DOI: https://doi.org/10.1002/cbf.3317

Bhardwaj, V., Nehra, S., Bansal, A., Saxena, S., Singh, M., & Saraswat, D. The effect of amlodipine in ameliorating the hypobaric hypoxia induced neuronal damages and dysfunction. International Journal of Pharmaceutical Sciences and Research, 2015, 6(7), 2770-80.

Briggs, M. W., & Sacks, D. B. IQGAP proteins are integral components of cytoskeletal regulation. EMBO Reports, June 2003, 4(6), 571–574. DOI: https://doi.org/10.1038/sj.embor.embor867

Chung, S., Kim, S., Kim, M., Koh, E. S., Yoon, H. E., Kim, H.-S., Park, C. W., Chang, Y. S., & Shin, S. J. T-type calcium channel blocker attenuates unilateral ureteral obstruction-induced renal interstitial fibrosis by activating the Nrf2 antioxidant pathway. American Journal of Translational Research, 2016, 8(11), 4574–4585.

Divolis, G., Mavroeidi, P., Mavrofrydi, O., & Papazafiri, P. Differential effects of calcium on PI3K-Akt and HIF-1α survival pathways. Cell Biology and Toxicology, October 25, 2016, 32(5), 437–449. DOI: https://doi.org/10.1007/s10565-016-9345-x

Fares, H., DiNicolantonio, J. J., O’Keefe, J. H., & Lavie, C. J. Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes. Open Heart, September 28, 2016, 3(2), e000473. DOI: https://doi.org/10.1136/openhrt-2016-000473

Gurkoff, G., Shahlaie, K., Lyeth, B., & Berman, R. Voltage-Gated Calcium Channel Antagonists and Traumatic Brain Injury. Pharmaceuticals, June 26, 2013, 6(7), 788–812. DOI: https://doi.org/10.3390/ph6070788

Kharroubi, A. T., & Darwish, H. M. Diabetes mellitus: The epidemic of the century. World Journal of Diabetes, June 25, 2015, 6(6), 850–867. DOI: https://doi.org/10.4239/wjd.v6.i6.850

Kim, J.-H., Xu, E. Y., Sacks, D. B., Lee, J., Shu, L., Xia, B., & Kong, A.-N. T. Identification and Functional Studies of a New Nrf2 Partner IQGAP1: A Critical Role in the Stability and Transactivation of Nrf2. Antioxidants & Redox Signaling, July 10, 2013, 19(2), 89–101. DOI: https://doi.org/10.1089/ars.2012.4586

Lee, D. H., Park, J. S., Lee, Y. S., Sung, S. H., Lee, Y.-H., & Bae, S. H. The hypertension drug, verapamil, activates Nrf2 by promoting p62-dependent autophagic Keap1 degradation and prevents acetaminophen-induced cytotoxicity. BMB Reports, February 2017, 50(2), 91–96. DOI: https://doi.org/10.5483/BMBRep.2017.50.2.188

Lisk, C., McCord, J., Bose, S., Sullivan, T., Loomis, Z., Nozik-Grayck, E., Schroeder, T., Hamilton, K., & Irwin, D. C. Nrf2 activation: A potential strategy for the prevention of acute mountain sickness. Free Radical Biology and Medicine, October 2013, 63, 264–273. DOI: https://doi.org/10.1016/j.freeradbiomed.2013.05.024

Nurlaela, S., Kurniawan, S. N., & Husna, M. Electroneuromyography Examination Of Diabetic Polyneuropathy Patients. MNJ (Malang Neurology Journal), January 1, 2019, 5(1), 1–4. DOI: https://doi.org/10.21776/ub.mnj.2019.005.01.1

RI, K. K. InfoDATIN: Situasi dan Analisi Diabetes. Kementrian Kesehatan RI, 2014, 1–2.

Rochette, L., Zeller, M., Cottin, Y., & Vergely, C. Diabetes, oxidative stress and therapeutic strategies. Biochimica et Biophysica Acta (BBA) - General Subjects, September 2014, 1840(9), 2709–2729. DOI: https://doi.org/10.1016/j.bbagen.2014.05.017

Shi, H., & Liu, K. J. Effects of glucose concentration on redox status in rat primary cortical neurons under hypoxia. Neuroscience Letters, December 13, 2006, 410(1), 57–61. DOI: https://doi.org/10.1016/j.neulet.2006.09.066

Singh, R., Kishore, L., & Kaur, N. Diabetic peripheral neuropathy: Current perspective and future directions. Pharmacological Research, February 2014, 80, 21–35. DOI: https://doi.org/10.1016/j.phrs.2013.12.005

Verkhratsky, A., & Fernyhough, P. Calcium signalling in sensory neurones and peripheral glia in the context of diabetic neuropathies. Cell Calcium, November 2014, 56(5), 362–371. DOI: https://doi.org/10.1016/j.ceca.2014.07.005

Downloads

Published

2020-01-31

How to Cite

NK, S., MTRR, N., H, M., & R, M. (2020). THE EFFECT OF 5 µM DOSAGE OF AMLODIPINE ON NRF2 EXPRESSION IN NEURON CULTURE INDUCED BY 25 mM OF GLUCOSE. International Journal of Research -GRANTHAALAYAH, 8(1), 287–293. https://doi.org/10.29121/granthaalayah.v8.i1.2020.283